Glioblastoma multiplex application note

In this study, we highlight how using a 40-plex antibody panel with the PhenoCycler® Fusion platform allowed us to investigate the spatial architecture of glioblastoma (GBM), the most aggressive and most common type of brain cancer.

Download now

Abcam will process your personal data in strict accordance with its privacy policy which can be found here. This will include sending you updates about Abcam, our products, and resources we think would be of interest to you. You can unsubscribe and manage your marketing preferences by clicking the link at the bottom of every email we send. By filling out this form you consent to Abcam sharing your details with your local, authorized distributor for the purpose of answering your query.

Progress happens together

  • Terms
  • Privacy policy
  • Legal

© 1998-2025 Abcam Limited. All rights reserved.